Treatment of recurrent ovarian cancer
Kitao, A.; Matsumoto, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 4): 628-633
2012
ISSN/ISBN: 0047-1852 PMID: 23156322 Document Number: 659231
Document emailed within 1 workday
Related Documents
Robová, H.; Rob, L.; Pluta, M.; Halaska, M.; Chmel, R. 2009: Treatment of recurrent ovarian cancer Ceska Gynekologie 74(6): 464-468Shershah, S. 1985: Treatment by combined chemotherapy for recurrent ovarian cancer JPMA. Journal of the Pakistan Medical Association 35(11): 341-343
Giseĭnov, K.D.; Beliaev, A.M.; Senchik, K.I.; Maksimov, S.I.; Urmancheeva, A.F.; Gafton, G.I.; Mikaia, N.A.; Beliaeva, O.A.; Kireeva, G.S.; Gorodnova, T.V.; Matveeva, N.S. 2014: Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer Voprosy Onkologii 60(3): 343-347
Akers, S.N.; Riebandt, G.; Miller, A.; Groman, A.; Odunsi, K.; Lele, S. 2013: Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study European Journal of Gynaecological Oncology 34(2): 113-119
Jin, Y.; Pan, L-ya.; Huang, H-fang.; Shen, K.; Wu, M.; Yang, J-xin.; Lang, J-he. 2006: Treatment options for patients with recurrent ovarian cancer: a review of 54 cases Chinese Medical Sciences Journal 21(1): 11-15
Demeter, A.; Sziller, I.; Csapo, Z.; Olah, J.; Keszler, G.; Jeney, A.; Papp, Z.; Staub, M. 2005: Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer Anticancer Research 25(4): 2885-2889
Uysal, M.; Ozdogan, M.; Kargi, A.; Gunduz, S.; Sezgin Goksu, S.; Murat Tatli, A.; Arslan, D.; Mutlu, H.; Senol Coskun, H.; Bozcuk, H. 2014: Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 980-984
Urabe, S.; Fujiwara, H.; Egawa, M.; Fujitou, N.; Sakashita, T.; Date, K.; Mizunoe, T.; Ueda, K.; Urabe, T. 2004: Recurrent ovarian cancer with cancer peritonitis treated with weekly paclitaxel infusion--a clinicopharmacological study Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(3): 449-451
Ding, X.; Lang, J.; Shen, K. 1999: Recurrent epithelial ovarian cancer Zhonghua Fu Chan Ke Za Zhi 34(1): 30-32
Nishimura, H.; Imamura, K.; Chang, C. 1996: Chemotherapy for recurrent ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1124-1128
Rose, P.G. 2000: Surgery for recurrent ovarian cancer Seminars in Oncology 27(3 Suppl 7: 17-23
2002: Recurrent ovarian cancer as chronic disease Oncology 16(4): 412 415
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Kataoka, F.; Tsuda, H.; Nomura, H.; Chiyoda, T.; Tominaga, E.; Suzuki, A.; Susumu, N.; Aoki, D. 2011: The chemosensitivity of nodal metastases in recurrent epithelial ovarian cancer European Journal of Gynaecological Oncology 32(2): 160-163
Thavaramara, T.; Tangjitgamol, S.; Manusirivithaya, S.; Leelahakorn, S. 2009: Oral etoposide for refractory or recurrent epithelial ovarian cancer Journal of the Medical Association of Thailand 92(11): 1397-1405
Wydra, D.; Emerich, J. 2002: Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer Ginekologia Polska 73(11): 1044-1047
Parveen, Z.; Qureshi, A.N.; Akbar, M.; Zafar, A.; Subhani, A. 2009: Palliative surgery for intestinal obstruction due to recurrent ovarian cancer Journal of Ayub Medical College Abbottabad: Jamc 21(1): 135-136
Satthapong, D.; Tangjitgamol, S.; Manusirivithaya, S.; Pataradool, K. 2007: Chemotherapy in patients with recurrent or refractory epithelial ovarian cancer Journal of the Medical Association of Thailand 90(3): 411-419
Klotz, R.; Zeimet, A.G.; Reimer, D.; Müller-Holzner, E.; Chamson, M.; Marth, C. 2008: Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancer Anticancer Research 28(5b): 2975-2980
Ding, X.-l.; Shen, K.; Lang, J.-h.; Wu, M.; Huang, H.-f.; Pan, L.-y.; Yang, J.-x. 2003: Role of positron emission tomography in diagnosis of recurrent ovarian cancer Zhonghua Fu Chan Ke Za Zhi 38(11): 667-669